|
Pressure BioSciences, Inc. Provides Update on Recent Equity Transactions
CNNMoney In consideration for the warrant holders exercising their outstanding warrants, the Company agreed to reduce the exercise price to $0.25 per warrant share. In addition, for each warrant exercised, the … Each unit consists of (i) one share of Series K … |
